Evidence mapPaperPMID 40067387Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2025

Serum Metabolomic Markers of Dietary Potassium and Risk of CKD.

Lauren Bernard, Jiaqi Yang, Jingsha Chen, Valerie K Sullivan, Bing Yu, Eugene P Rhee, Paul A Welling, Casey M Rebholz

Abstract read
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Potassium and the kidney.Nature reviews. Nephrology · 2026
    Review
  2. Plasma Proteomic Profile of Dietary Potassium and Incident CKD.Clinical journal of the American Society of Nephrology : CJASN · 2026
    Article
  3. Metabolomic Signature of Dietary Potassium Intake: A Novel Approach to Understanding CKD Onset?Clinical journal of the American Society of Nephrology : CJASN · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lauren BernardDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.ORCID 0000-0001-5747-3747
Jiaqi YangDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.ORCID 0000-0003-4083-4993
Jingsha ChenDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Valerie K SullivanDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.ORCID 0000-0002-2321-0188
Bing YuDepartment of Epidemiology, School of Public Health, University of Texas Health Science Center at Houston, Houston, Texas.ORCID 0000-0003-4818-1077
Eugene P RheeDivision of Nephrology and Endocrine Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Paul A WellingDivision of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland.ORCID 0000-0002-0719-8705
Casey M RebholzDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.ORCID 0000-0002-5442-8745

Funding

THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - COORDINATING CENTER - TASK AREA B.2 AND B.375N92022D00001 · UNIV OF NORTH CAROLINA CHAPEL HILL · 2025 to 2025
$3.8M
Molecular of ROMK Channel FunctionR01DK054231 · UNIVERSITY OF MARYLAND BALTIMORE · 1998 to 2025
$1.8M
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A75N92022D00005 · WAKE FOREST UNIVERSITY HEALTH SCIENCES · 2025 to 2025
$1.5M
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A75N92022D00003 · UNIVERSITY OF MINNESOTA · 2025 to 2025
$1.5M
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A75N92022D00004 · UNIVERSITY OF MISSISSIPPI MED CTR · 2025 to 2025
$1.4M
Premature aging disorders, metabolites, and atherosclerosisR01HL163857 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · 2024 to 2025
$1.4M
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A75N92022D00002 · JOHNS HOPKINS UNIVERSITY · 2025 to 2025
$1.4M
Resource Development CoreU54DK137331 · JOHNS HOPKINS UNIVERSITY · 2025 to 2025
$857k
WNK-SPAK signaling in the Distal NephronR01DK093501 · VANDERBILT UNIVERSITY MEDICAL CENTER · 2025 to 2025
$725k
Coordinated SLC12A3/SLC12A6/SL26A4 electroneutral transport pathways maintain K+ homeostasis and acid-base balanceR01DK110375 · VANDERBILT UNIVERSITY MEDICAL CENTER · 2025 to 2025
$717k
Molecular Determinants of Atherosclerotic Cardiovascular Disease in Multi-ethnic PopulationsR01HL168683 · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · 2025 to 2025
$708k
Genetic Architecture of Cardiac Structure and Function and Its Impact on Heart FailureR01HL160793 · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · 2025 to 2025
$702k
NHGRI NIH HHS 3U01HG004402-02S1NHGRI NIH HHS U01 HG004402NHLBI NIH HHS 75N92022D00001NHLBI NIH HHS 75N92022D00001, 75N92022D00002, 75N92022D00003, 75N92022D00004, 75N92022D00005NHLBI NIH HHS 75N92022D00002NHLBI NIH HHS 75N92022D00003NHLBI NIH HHS 75N92022D00004NHLBI NIH HHS 75N92022D00005NHLBI NIH HHS R01 HL153178NHLBI NIH HHS R01 HL160793NHLBI NIH HHS R01HL160793; R01HL168683; R01HL163857NHLBI NIH HHS R01 HL163857NHLBI NIH HHS R01 HL168683NIDDK NIH HHS R01 DK054231NIDDK NIH HHS R01DK054231; U54DK137331; R01DK093501; R01DK110375; R25DK139778NIDDK NIH HHS R01 DK093501NIDDK NIH HHS R01 DK110375NIDDK NIH HHS R25 DK139778NIDDK NIH HHS U54 DK137331NIDDK NIH HHS U54DK137331
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CKDcohort studiesmetabolomicsnutrition

Identifiers

PMID40067387
PMCPMC12097188

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.